Table 2.

The “vaccinated completely” group criteria for children born in 2017 and 2018.

Patient’s Age	PCV10 1	PCV13 2
From 6 weeks to 6 months of age	3+1 1. Three primary doses with an interval of at least 1 month between doses. 2. A booster dose at least 6 months after the last primary dose and from the age of 9 months. OR 2+1 1. Two primary doses with an interval of at least 2 months between doses. 2. A booster dose at least 6 months after the last primary dose and form the age of 9 months.	3+1 1. Three primary doses with an interval of at least 1 month between doses. 2. A booster dose is recommended between 11 and 15 months of age. OR 2+1 1. Two primary doses with an interval of at least 2 months between doses. 2. A booster dose is recommended between 11 and 15 months of age.
7 months–11 months	2+1 1. Two primary doses with an interval of at least 1 month between doses. 2. A booster dose in the second year of life, at least 2 months after the last primary dose.	2+1 1. Two primary doses with an interval of at least 1 month between doses. 2. A booster dose is recommended in the second year of life
12 months–23 months	2+0 1. Two doses with an interval of at least 2 months between doses.	2+0 1. Two doses with an interval of at least 2 months between doses
24 months–5 years		1+0 1. One single dose
5 years and above	Not registered for use.

¹ PCV10—10-valent conjugate pneumococcal vaccine; ² PCV13—13-valent conjugate pneumococcal vaccine.